Providence Capital Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.88M | Buy |
7,395
+1,500
| +25% | +$350K | 0.28% | 85 |
|
|
2026
Q1 | $1.44M | Sell |
5,895
-250
| -4% | -$58.2K | 0.24% | 87 |
|
|
2025
Q4 | $1.27M | Buy |
6,145
+50
| +0.8% | +$9.89K | 0.21% | 87 |
|
|
2025
Q3 | $1.13M | Sell |
6,095
-11
| -0.2% | -$1.89K | 0.2% | 84 |
|
|
2025
Q2 | $933K | Buy |
6,106
+3,166
| +108% | +$487K | 0.17% | 92 |
|
|
2025
Q1 | $488K | Buy |
2,940
+1
| +0% | +$156 | 0.1% | 103 |
|
|
2024
Q4 | $425K | Sell |
2,939
-170
| -5% | -$26.3K | 0.09% | 103 |
|
|
2024
Q3 | $504K | Sell |
3,109
-37,800
| -92% | -$6.02M | 0.1% | 101 |
|
|
2024
Q2 | $5.98M | Buy |
40,909
+4,500
| +12% | +$669K | 1.3% | 26 |
|
|
2024
Q1 | $5.76M | Buy |
36,409
+33,208
| +1,037% | +$5.29M | 1.26% | 33 |
|
|
2023
Q4 | $502K | Buy |
3,201
+108
| +3% | +$16.6K | 0.12% | 96 |
|
|
2023
Q3 | $482K | Buy |
3,093
+42
| +1% | +$6.93K | 0.13% | 97 |
|
|
2023
Q2 | $505K | Sell |
3,051
-27,600
| -90% | -$4.45M | 0.13% | 94 |
|
|
2023
Q1 | $4.75M | Buy |
30,651
+27,307
| +817% | +$4.41M | 1.26% | 33 |
|
|
2022
Q4 | $591K | Sell |
3,344
-24,943
| -88% | -$4.31M | 0.16% | 91 |
|
|
2022
Q3 | $4.62M | Buy |
28,287
+25,020
| +766% | +$4.23M | 1.39% | 18 |
|
|
2022
Q2 | $580K | Sell |
3,267
-170
| -5% | -$30.3K | 0.17% | 95 |
|
|
2022
Q1 | $577K | Buy |
3,437
+42
| +1% | +$7.15K | 0.14% | 108 |
|
|
2021
Q4 | $581K | Sell |
3,395
-181
| -5% | -$29.6K | 0.16% | 87 |
|
|
2021
Q3 | $578K | Buy |
3,576
+303
| +9% | +$51.7K | 0.18% | 82 |
|
|
2021
Q2 | $539K | Buy |
3,273
+605
| +23% | +$100K | 0.17% | 85 |
|
|
2021
Q1 | $438K | Buy |
2,668
+241
| +10% | +$39K | 0.16% | 85 |
|
|
2020
Q4 | $382K | Sell |
2,427
-121
| -5% | -$17.9K | 0.16% | 84 |
|
|
2020
Q3 | $379K | Hold |
2,548
| – | – | 0.2% | 74 |
|
|
2020
Q2 | $358K | Sell |
2,548
-349
| -12% | -$50.9K | 0.2% | 72 |
|
|
2020
Q1 | $380K | Buy |
2,897
+86
| +3% | +$12.2K | 0.23% | 76 |
|
|
2019
Q4 | $410K | Buy |
2,811
+581
| +26% | +$78.8K | 0.22% | 78 |
|
|
2019
Q3 | $289K | Hold |
2,230
| – | – | 0.17% | 82 |
|
|
2019
Q2 | $311K | Sell |
2,230
-162
| -7% | -$22.4K | 0.18% | 83 |
|
|
2019
Q1 | $334K | Sell |
2,392
-190
| -7% | -$25.4K | 0.21% | 82 |
|
|
2018
Q4 | $333K | Sell |
2,582
-165
| -6% | -$23K | 0.23% | 85 |
|
|
2018
Q3 | $380K | Sell |
2,747
-300
| -10% | -$39.9K | 0.25% | 83 |
|
|
2018
Q2 | $370K | Sell |
3,047
-425
| -12% | -$53K | 0.26% | 86 |
|
|
2018
Q1 | $445K | Sell |
3,472
-125
| -3% | -$16.9K | 0.33% | 80 |
|
|
2017
Q4 | $503K | Buy |
+3,597
| New | +$501K | 0.39% | 74 |
|
Other funds holding JNJ
Providence Capital Advisors's JNJ Position: Q2 2026 in Review
Providence Capital Advisors increased its Johnson & Johnson (JNJ) stake by 25% in Q2 2026, buying an estimated $350K and bringing the position to 7,395 shares worth $1.88M. The position accounts for 0.28% of the portfolio, ranked #85.
Providence Capital Advisors first reported a position in JNJ in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.98M in Q2 2024. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Providence Capital Advisors held 7,395 shares of Johnson & Johnson worth $1.88M as of Q2 2026.
- Providence Capital Advisors bought 1,500 Johnson & Johnson shares in Q2 2026, an estimated $350K.
- Johnson & Johnson made up 0.28% of Providence Capital Advisors's portfolio in Q2 2026, its #85 holding.
- Providence Capital Advisors first reported a position in Johnson & Johnson in Q4 2017 and has held it in 35 quarters since.
- Providence Capital Advisors's Johnson & Johnson position peaked at $5.98M in Q2 2024.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.